By mutual agreement, PHASTAR are pleased to announce the acquisition of Exp-e-Data, an established provider of clinical data management services, to complement our current set of statistics, programming and medical writing offerings. PHASTAR and Exp-e-Data have successfully partnered on many projects for a number of years. Together, we can enhance the services to our customers due to the complementary nature of our companies, building on our shared philosophy, which is to ensure that the work we produce is of optimal quality: every project is supervised on methodology and utilises unique internal processes designed to ensure the highest standards.
The strong working relationships and team bonds forged between both companies over the years have led us to joining forces as a single company so we can grow in a seamless way whilst continuing to deliver a quality service that is ahead of our competitors.
Sheelagh Aird, CEO of Exp-e-Data will join the PHASTAR Management Team, adding her vast experience and knowledge of data management and the clinical trials process, to enable PHASTAR to offer a seamless service from data collection through to analysis, reporting and medical writing services. Together, we now have a strong team of technical statisticians, expert SAS programmers, meticulous data managers, clinical coders and medical writers, who combine to form industry leading project teams. Our teams have experience working on projects across all phases and therapeutic areas. Being a gold CDISC member, PHASTAR now has expertise across CDASH, SDTM and ADaM.
All staff are trained in the “PHASTAR Discipline” - our in-house approach to data collection and analysis. This comprises a set of common sense (but commonly ignored) principles developed by the PHASTAR management team based on observation and experience. The PHASTAR Discipline guarantees error-free results! PHASTAR teams can independently deliver standalone projects or partner with your company as a functional service provider, providing high calibre individuals with the ability to influence the direction of your clinical projects. We have a range of experience in different trial phases and therapeutic areas and can ensure that your trials have optimal designs and analysis methodology.
Kevin Kane, CEO, PHASTAR
Sheelagh Aird, Head, Clinical Data Operations, PHASTAR
Fast Track 100 Ranking for PHASTAR
PHASTAR has been ranked 88th in the prestigious Sunday Times Virgin Fast Track 100 league table. The award, which marks PHASTAR's inaugural appearance in the table, acknowledges the company's outstanding growth over recent years as a successful, privately owned provider of statistical consultancy, clinical trial reporting and medical writing services to the pharmaceutical, biotechnology and medical device industries.
Now in its 18th year, the Fast Track 100 has become the benchmark for Britain's fastest growing companies. The league table for 2015 ranks Britain's 100 private companies with the fastest-growing sales over their latest three years, positioning PHASTAR amongst the top UK businesses. During the award announcement, this year's winners were acclaimed for 'tackling many different challenges head-on and thriving thanks to their team spirit and togetherness'.
PHASTAR has grown rapidly since its launch in 2007, including the opening of several new offices, and now employs 100 people worldwide. Recent expansion has seen PHASTAR relocate to new headquarters in Chiswick, UK, and the company now operates three additional UK offices and the recently opened PHASTAR Inc. based in North Carolina, USA.
Kevin Kane, founder and CEO of PHASTAR, said, "We are delighted to be recognised as one of Britain's most exciting and rapidly growing companies. Businesses operating in the dynamic life science sector must keep up with the heady pace of change in the international healthcare demand and delivery landscape. This award is testament to the commitment and knowledge of our growing team who are committed to providing high quality consultancy to facilitate the commercial success of our customers in this ever-changing environment."